- Home
- ANIX vs CTM Comparison
ANIX vs CTM Comparison
Compare ANIX & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIX | CTM |
|---|---|---|
| Founded | 1982 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 93.7M |
| IPO Year | 2013 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ANIX | CTM |
|---|---|---|
| Price | $2.95 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $9.00 | $3.00 |
| AVG Volume (30 Days) | 141.7K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.82 | ★ 52.63 |
| EPS | N/A | ★ N/A |
| Revenue | $210,000.00 | ★ $44,764,852.00 |
| Revenue This Year | N/A | $23.00 |
| Revenue Next Year | N/A | $11.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.33 | $0.79 |
| 52 Week High | $5.46 | $1.67 |
Technical Indicators
Market Signals| Indicator | ANIX | CTM |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 56.00 |
| Support Level | $2.69 | $0.95 |
| Resistance Level | $3.00 | $1.13 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 70.42 | 89.00 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.